Nucleic Acid-Tagged Screening Arrays for Precise Hit Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current high throughput screening methods for small molecules, proteins, and cells face challenges such as complexity, cross-contamination, and inefficiencies in detecting and characterizing candidate agents for therapeutic and other functional properties.

Innovation Solution

A method involving nucleic acid tagging and sequencing is employed to form arrays of candidate agents on a solid support, allowing for high throughput screening by detecting reactions and identifying 'hits' based on spatially resolved detection and sequencing of nucleic acid tags.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional high throughput screening methods are used to screen small molecule libraries, then large numbers of compounds can be screened, but the process requires multiple independent assays and platforms increasing complexity and cost

Engineering Contradiction:
Improvethroughput of compound screeningVSAvoidnumber of independent platforms and assays
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines multiple independent screening assays into a single integrated platform. Different assay types (binding assays, functional assays, toxicity screens) are performed simultaneously on the same microarray platform, eliminating the need for separate platforms and reducing overall system complexity while maintaining high throughput capability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microarray platform is designed with universal features that can accommodate multiple types of assays and detect multiple targets simultaneously. The system uses universal detection methods (such as fluorescence detection) that can measure various biological interactions through a single integrated system rather than requiring specialized equipment for each assay type

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If emulsion based screening methods are used for rapid protein evolution, then throughput and speed are improved, but cross-contamination and difficulty in recovering components occur

Engineering Contradiction:
Improvespeed of protein evolution screeningVSAvoidcross-contamination between samples
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent segments samples into spatially separated individual locations on a solid support surface. Each sample is immobilized at a discrete position on the microarray, creating physical barriers that prevent cross-contamination while maintaining high throughput. This spatial segmentation replaces the emulsion droplet isolation approach with solid-phase spatial separation

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The solid support surface acts as an intermediary that immobilizes samples and reagents in defined spatial locations. This intermediary platform enables precise control over sample interactions while preventing unwanted cross-contamination, serving as a stable mediator between the screening reagents and detection systems

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If fluorescence activated cell sorting is used for cellular screening, then high throughput is achieved, but only snapshots of cellular behavior are captured without temporal dynamics

Engineering Contradiction:
Improvethroughput of cell screeningVSAvoidtemporal dynamics of cellular behavior
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent implements continuous monitoring of cellular behavior through time-resolved detection methods. Instead of capturing single time-point snapshots, the system continuously measures cellular responses over time at each microarray location, maintaining high throughput while preserving temporal information through automated sequential detection cycles

Inventive Principle:
Principle #20Continuity of useful action

4Measurement precision

If conventional sequencing methods are used to identify candidate agents, then accuracy is maintained, but throughput is limited and cannot keep pace with large library screening

Engineering Contradiction:
Improveaccuracy of candidate identificationVSAvoidthroughput of candidate agent identification
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent uses nucleic acid tags as informational copies that link physical candidate agents to their digital sequences. Each candidate agent is associated with a unique nucleic acid tag that can be rapidly amplified and sequenced. This copying approach allows parallel processing of thousands of candidates through next-generation sequencing technologies, maintaining identification accuracy while achieving high throughput through information replication

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high throughput screening with spatial and temporal resolution, allowing for precise identification of candidate agents with desired properties, improving efficiency and accuracy over traditional methods.

Implementation Method 1

sequencing the nucleic acid tags on the array to determine the tag sequence that is attached to each of the candidate agents

Methodology Applied
Scientific EffectSequencing:

Data Source

PatentUS12559864B2Platform for discovery and analysis of therapeutic agents
Publication Date: 2026.02.24 ILLUMINA INC
  • US12559864B2 patent drawing
  • US12559864B2 patent drawing
  • US12559864B2 patent drawing

AI summary

A method of characterizing candidate agents including steps of (a) providing a library of candidate agents attached to nucleic acid tags; (b) contacting the library with a solid support to attach the candidate agents to the solid support, whereby an array of candidate agents is formed; (c) contacting the array with a screening agent, wherein one or more candidate agents in the array react with the screening agent; (d) detecting the array to determine that at least one candidate agent in the array reacts with the screening agent; (e) sequencing the nucleic acid tag to determine the tag sequences attached to candidate agents in the array; and (f) identifying the at least one candidate agent in the array that reacts with the screening agent based on the tag sequence that is attached to the at least one candidate agent.